Regenerative Wound Healing: The Role of Interleukin-10

Alice King,Swathi Balaji,Louis D. Le,Timothy M. Crombleholme,Sundeep G. Keswani
DOI: https://doi.org/10.1089/wound.2013.0461
2014-04-01
Advances in Wound Care
Abstract:<b>Significance:</b> Postnatal wounds heal with characteristic scar formation. In contrast, the mid-gestational fetus is capable of regenerative healing, which results in wound repair that is indistinguishable from uninjured skin. However, the underlying mechanisms of fetal regenerative phenotype are unknown. <b>Recent Advances:</b> The potent anti-inflammatory cytokine, interleukin-10 (IL-10), plays an essential role in the ability of the fetus to heal regeneratively and has been shown to recapitulate scarless healing in postnatal tissue. IL-10's ability to facilitate regenerative healing is likely a result of pleiotropic effects, through regulation of the inflammatory response, as well as novel roles as a regulator of the extracellular matrix, fibroblast cellular function, and endothelial progenitor cells. Overexpression of IL-10 using a variety of methods has been demonstrated to recapitulate the fetal regenerative phenotype in post-natal tissue, in conjunction with promising results of Phase II clinical trials using recombinant IL-10. <b>Critical Issues:</b> Successful wound healing is a complex process that requires coordination of multiple growth factors, cell types, and extracellular cellular matrix components. IL-10 has been demonstrated to be critical in the fetus' intrinsic ability to heal without scars, and, further, can induce scarless healing in postnatal tissue. The mechanisms through which IL-10 facilitates this regeneration are likely the result of IL-10's pleiotropic effects. Efforts to develop IL-10 as an anti-scarring agent have demonstrated promising results. <b>Future Directions:</b> Further studies on the delivery, including dose, route, and timing, are required in order to successfully translate these promising findings from <i>in vitro</i> studies and animal models into clinical practice. IL-10 holds significant potential as an anti-scarring therapeutic.
dermatology
What problem does this paper attempt to address?